egc-encoded superantigens from Staphylococcus aureus are neutralized by human sera much less efficiently than are classical staphylococcal enterotoxins or toxic shock syndrome toxin

Infection and Immunity

Volumn 72, Issue 7, 2004, Pages 4061-4071

  Holtfreter, Silva ^a   Bauer, Kristin ^a   Thomas, Damien ^b   Feig, Christine ^a   Lorenz, Vera ^a   Roschack, Katharina ^a   Friebe, Erika ^a   Selleng, Kathleen ^a   Lövenich, Sandra ^a   Greve, Timm ^a,c   Greinacher, Andreas ^a   Panzig, Brigitte ^a   Engelmann, Susanne ^a   Lina, Gérard ^b   Bröker, Barbara M ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b INSERM   (France)

^c Artus Biotech GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; STAPHYLOCOCCUS ENTEROTOXIN; STAPHYLOCOCCUS ENTEROTOXIN G; STAPHYLOCOCCUS ENTEROTOXIN I; STAPHYLOCOCCUS ENTEROTOXIN M; STAPHYLOCOCCUS ENTEROTOXIN N; STAPHYLOCOCCUS ENTEROTOXIN O; SUPERANTIGEN; SUPERANTIGEN EGC; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BLOOD CULTURE; FEMALE; GENE CLUSTER; GENE FUNCTION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEA GENE; SEQ GENE; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; THROAT CULTURE; TST GENE;

ADULT; BACTERIAL TOXINS; ENTEROTOXINS; FEMALE; HUMANS; MALE; SERUM; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 3042683593     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.7.4061-4071.2004     Document Type: Article

References (40)

1. Arad, G., R. Levy, D. Hillman, and R. Kaempfer. 2000. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Nat. Med. 6:414-421.
2. Arcus, V. L., R. Langley, T. Proft, J. D. Fraser, and E. N. Baker. 2002. The three-dimensional structure of a superantigen-like protein, SET3, from a pathogenicity island of the Staphylococcus aureus genome. J. Biol. Chem. 277:32274-32281.
3. Baba, T., F. Takeuchi, M. Kuroda, H. Yuzawa, K. Aoki, A. Oguchi, Y. Nagai, N. Iwama, K. Asano, T. Naimi, H. Kuroda, L. Cui, K. Yamamoto, and K. Hiramatsu. 2002. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359:1819-1827.
4. Banks, M. C., N. S. Kamel, J. B. Zabriskie, D. H. Larone, D. Ursea, and D. N. Posnett. 2003. Staphylococcus aureus express unique superantigens depending on the tissue source. J. Infect. Dis. 187:77-86.
5. Bannan, J., K. Visvanathan, and J. B. Zabriskie. 1999. Structure and function of streptococcal superantigens in septic shock. Bacterial Sepsis Septic Shock 13:387-396.
6. Bentley, M., D. Borst, and L. Regassa. 1992. Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: a compararive study of their molecular biology. Chem. Immunol. 55:1-35.
7. Blank, C., A. Luz, S. Bendigs, A. Erdmann, H. Wagner, and K. Heeg. 1997. Superantigen and endotoxin synergize in the induction of lethal shock. Eur. J. Immunol. 27:825-833.
8. Darenberg, J., N. Ihendyane, J. Sjolin, E. Aufwerber, S. Haidl, P. Follin, J. Andersson, and A. Norrby-Teglund. 2003. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 37:333-340.
9. Dinges, M. M., and P. Schlievert. 2001. Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in mice. Infect. Immun. 69:1256-1264.
10. Fitzgerald, J., S. Reid, E. Ruotsalainen, T. Tripp, M. Liu, R. Cole, P. Kuusela, P. Schlievert, A. Järvinen, and J. Musser. 2003. Genome diversification in Staphylococcus aureus: Molecular evolution of a highly variable chromosomal region encoding the staphylococcal exotoxin-like family of proteins. Infect. Immun. 71:2827-2838.
11. Jarraud, S., G. Cozon, F. Vandenesch, M. Bes, J. Etienne, and G. Lina. 1999. Involvement of enterotoxin G and I in staphylococcal toxic shock syndrome and styphylococcal scarlet fever. J. Clin. Microbiol. 37:2446-2449.
12. Jarraud, S., C. Mougel, J. Thioulouse, G. Lina, H. Meugnier, F. Forey, X. Nesme, J. Etienne, and F. Vandenesch. 2002. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect. Immun. 70:631-641.
13. Jarraud, S., M. A. Peyrat, A. Lim, A. Tristan, M. Bes, C. Mougel, J. Etienne, F. Vandenesch, M. Bonneville, and G. Lina. 2001. egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus. J. Immunol. 166:669-677.
14. Kalmeijer, M., H. Coertjens, P. von Nieuwland-Bollen, D. Bogaers-Hofman, G. de Baere, A. Stuurman, A. van Belkum, and J. Kluytmans. 2002. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double blind, randomized placebo-controlled study. Clin. Infect. Dis. 35:353-358.
15. Kaul, R., A. McGeer, A. Norrby-Teglund, M. Kotb, B. Schwartz, K. O'Rourke, J. Talbot, and D. E. Low. 1999. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. The Canadian Streptococcal Study Group. Clin. Infect. Dis. 28:800-807.
16. Kluytmans, J., J. Mouton, E. Ijzerman, Vandenbroucke-Grauls, A. Maat, J. Wagenvoort, and H. Verbrugh. 1995. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J. Infect. Dis. 171:216-219.
17. Kotb, M., A. Norrby-Teglund, A. McGeer, H. El-Sherbini, M. T. Dorak, A. Khurshid, K. Green, J. Peeples, J. Wade, G. Thomson, B. Schwartz, and D. E. Low. 2002. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat. Med. 8:1398-1404.
18. Kuroda, M., T. Ohta, I. Uchiyama, T. Baba, H. Yuzawa, I. Kobayashi, L. Cui, A. Oguchi, K. Aoki, Y. Nagai, J. Lian, T. Ito, M. Kanamori, H. Matsumaru, A. Maruyama, H. Murakami, A. Hosoyama, Y. Mizutani-Ui, N. K. Takahashi, T. Sawano, R. Inoue, C. Kaito, K. Sekimizu, H. Hirakawa, S. Kuhara, S. Goto, J. Yabuzaki, M. Kanehisa, A. Yamashita, K. Oshima, K. Furuya, C. Yoshino, T. Shiba, M. Hattori, N. Ogasawara, H. Hayashi, and K. Hiramatsu. 2001. Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet 357:1225-1240.
19. Kyte, J., and F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105.
20. LeClaire, R. D., and S. Bavari. 2001. Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethality. Antimicrob. Agents Chemother. 45:460-463.
21. Lowy, F. 1988. Staphylococcus aureus infections. N. Engl. J. Med. 339:520-529.
22. McCormick, J. K., J. M. Yarwood, and P. M. Schlievert. 2001. Toxic shock syndrome and bacterial superantigens: an update. Annu. Rev. Microbiol. 55:77-104.
23. Meyer, R., S. Monday, G. Bohach, and S. Schlievert. 2001. Prolonged course of toxic shock syndrome associated with methicillin-resistant Staphylococcus aureus enterotoxins G and I. Int. J. Infect. Dis. 5:163-166.
24. Monday, S., and G. Bohach. 1999. Use of multiplex PCR to detect classical and newly described pyrogenic toxin genes in staphylococcal isolates. J. Clin. Microbiol. 37:3411-3414.
25. Munson, S. H., M. T. Tremaine, M. J. Betley, and R. A. Welch. 1998. Identification and characterization of staphylococcal enterotoxin types G and I from Staphylococcus aureus. Infect. Immun. 66:3337-3348.
26. Nilsson, I.-M., M. Vedrengh, R. Ulrich, S. Bavari, and A. Tarkowski. 1999. Protection against Staphylococccus aureus Sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity. J. Infect. Dis. 180:1370-1373.
27. Norrby-Teglund, A., S. Chatellier, D. E. Low, A. McGeer, K. Green, and M. Kotb. 2000. Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur. J. Immunol. 30:3247-3255.
28. Norrby-Teglund, A., G. T. Nepom, and M. Kotb. 2002. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles. Eur. J. Immunol. 32:2570-2577.
29. Norrby-Teglund, A., S. R. Norrby, and D. E. Low. 2003. The treatment of severe group a streptococcal infections. Curr. Infect. Dis. Rep. 5:28-37.
30. Omoe, K., M. Ishikawa, Y. Shimoda, D.-L. Hu, S. Ueda, and K. Shinagawa. 2002. Detection of seg, seh, and sei genes in Staphylococcus aureus isolates and determination of the enterotoxin productivities of S. aureus isolates harboring seg, seh, or sei genes. J. Clin. Microbiol. 40:857-862.
31. Perl, T., J. Cullen, R. Wenzel, M. Zimmerman, M. Pfaller, D. Sheppard, J. Twombley, P. French, and L. Herwaldt. 2002. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N. Engl. J. Med. 346:1871-1877.
32. Proft, T., and J. Fraser. 1998. Superantigens: just like peptides, only different. J. Exp. Med. 187:819-821.
33. Proft, T., S. L. Moffatt, K. D. Weller, A. Paterson, D. Martin, and J. D. Fraser. 2000. The streptococcal superantigen SMEZ exhibits wide allelic variation, mosaic structure, and significant antigenic variation. J. Exp. Med. 191:1765-1776.
34. Stolz, S., J. Davis, J. Vergeront, B. Crass, P. Chesney, P. Wand, and M. Bergdoll. 1885. Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in Wisconsin. J. Infect. Dis. 151:883-889.
35. Ulrich, R. G., M. Olson, and S. Bavari. 1998. Development of engineered vaccines effective against structurally related bacterial superantigens. Vaccine 16:1857-1864.
36. Vergeront, J., S. Stolz, B. Crass, D. Nelson, J. Davis, and M. Bergdoll. 1983. Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implication for toxic-shock syndrome. J. Infect. Dis. 4:692-698.
37. von Eiff, C., K. Becker, K. Machka, H. Stammer, and G. Peters. 2001. Nasal Carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344:11-16.
38. Wenzel, R., and T. Perl. 1995. The significance of nasal carriage of Staphylococcus aureus in the incidence ot postoperative wound infection. J. Hosp. Infect. 1:13-24.
39. Williams, R. J., J. M. Ward, B. Henderson, S. Poole, B. P. O'Hara, M. Wilson, and S. P. Nair. 2000. Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterization of the prototypic gene and its protein product, SET1. Infect. Immun. 68:4407-4415.
40. Yarwood, J. M., J. K. McCormick, M. L. Paustian, P. M. Orwin, V. Kapur, and P. M. Schlievert. 2002. Characterization and expression analysis of Staphylococcus aureus pathogenicity island 3. Implications for the evolution of staphylococcal pathogenicity islands. J. Biol. Chem. 277:13138-13147.